Minimal Residual Disease Testing Market Propelled by Growing...

ha aggiunto un file Altre informazioni

2024-06-07 13:56:00 -

Minimal Residual Disease Testing Market Propelled by Growing Adoption of Standardized Diagnostic Testing

The Minimal Residual Disease Testing market involves the monitoring of response to anti-cancer therapies by detecting and quantifying residual malignant disease below the threshold of conventional detection methods. It enables assessment of treatment response through detection of cancer cells at frequencies as low as 1 in 104-105 nucleated cells, thereby allowing for treatment strategy...

0 Commenti 0 condivisioni 790 Views 0 Anteprima